An interventional study of shock wave treatment control group and shock wave treatment experimental group in Plantar Fasciitis, sponsored by University of Alcala. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-09-19.
Sponsored by University of Alcala · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 20 studies in Fasciitis, Plantar with a site in Spain — 5 open to participants now, 5 under way, none of them phase 3. Fasciitis, Plantar · Spain.
Among the 20 studies in Fasciitis, Plantar with a site in Spain, this one is the 10th largest by planned enrollment of the 19 interventional ones that give a count, is one of 3 that started in 2024, is one of 17 with no phase, and was the 16th registered.
224 studies on the registry are indexed under Fasciitis, Plantar; 59 are open to participants now.
Browse Fasciitis, Plantar studies →5 of the 20 studies in Fasciitis, Plantar with a site in Spain are open now. Recruiting first, the newest first:
ReSport Clinic · Sites in Spain
Ages 18+
Universidad Europea de Valencia · Sites in Spain
Ages 30–65
University of Seville · Sites in Spain
Ages 18–50
Wroclaw University of Health and Sport Sciences · Sites in Spain
Ages 18–60
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 29 Fasciitis, Plantar studies recruiting now, 5 (17%) set no upper age limit and 21 (72%) stop at 75 or younger; none take children under 18; 4 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 3 started in 2024.
This study's planned enrollment of 48 is below the median of 56 across 194 interventional studies indexed under Fasciitis, Plantar.
Median enrollment 48 across the 19 interventional studies, 2,000 across the 1 observational. Of the 13 that completed or were terminated, 1 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 20 has an industry lead sponsor. The 10 most frequent:
University of Alcala is the lead sponsor of 128 studies on the registry; 36 are open to participants now.
University of Alcala has 1 study filed under Fasciitis, Plantar — fewer than ten, so there is no comparison to draw.
1 of the studies in Fasciitis, Plantar with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07654660Universidad Europea de ValenciaMultimodal Conservative Intervention Versus Surgery for Chronic Refractory Plantar Fasciopathy | 2027-09 |
Add it to your calendar (.ics) → With an account.
Among the 20 studies in Fasciitis, Plantar with a site in Spain, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The study focuses on plantar fasciitis, one of the most common causes of non-traumatic foot and ankle pain, with an estimated prevalence of 10%. Its objective is to evaluate the effectiveness of shock wave therapy applied along the course of the sciatic nerve in treating plantar fasciitis, comparing its effects on pain, foot-ankle functionality, and quality of life.
Forty-eight subjects will be recruited and randomly assigned to two groups: one will receive local shock wave therapy, while the other will receive therapy along the sciatic nerve. Data will be collected at four points in time: before the intervention, one week after, one month after, and three months after, with blinded data collection.
Pain, foot-ankle functionality, and quality of life will be measured. Data analysis will be performed using SPSS 29.0, applying ANOVA and other tests depending on the normality of the data. Differences will be estimated with a 95% confidence interval and a p-value \< 0.05.
Introduction: Plantar fasciitis is one of the most common causes of non-traumatic ankle-foot pain. The exact prevalence is unknown, but it is estimated to be around 10%.
Objective: To evaluate the efficacy of applying shock waves along the course of the sciatic nerve in the treatment of plantar fasciitis and its effect on pain, as well as to assess changes in ankle-foot functionality and quality of life.
Material and Methods: Forty-eight subjects who meet the inclusion criteria will be recruited and randomly assigned to each intervention group. The control group will receive local shock wave therapy, while the experimental group will receive shock wave therapy along the course of the sciatic nerve.
Data Collection: Data will be collected at four different times: before the intervention, one week after, one month after, and three months after. The data collection will be carried out by a team member who will be blinded to the group to which the subject belongs. The dependent variables to be measured are pain (VAS scale), ankle-foot functionality (FFI), and quality of life (SF12).
Data Analysis: The data analysis will use SPSS 29.0. Normality of variables will be assessed, and descriptive analyses will be conducted. Initial homogeneity between groups will be compared, and ANOVA and other tests will be applied according to normality and homoscedasticity. Differences and percentage changes will be calculated, estimating effect size, with a 95% CI and p \< .05.
Inclusion criteria: having been diagnosed with plantar fasciitis, experiencing pain related to the condition for at least 1 month, and being between 18 and 65 years of age.
Exclusion criteria: being pregnant, having a pacemaker, presenting with rheumatoid arthritis, or having coagulation disorders.
A group of 24 people receive shock waves along the leg to treat their plantar fasciitis.
Other: shock wave treatment experimental group
A group of 24 people receive shock waves on the sole of the foot to treat their plantar fasciitis
Other: shock wave treatment control group
The control group, consisting of 24 people, will receive shock wave treatment on the sole of the foot to treat plantar fasciitis. There will be 4 sessions and 4 data collections.
The experimental group, consisting of 24 people, will receive shockwave treatment on the back of the leg to treat plantar fasciitis. There will be 4 sessions and 4 data collections.
pain (EVA scale)
Assess changes in pain in plantar fasciitis after treatments
Time frame: 3 months
ankle-foot functionality (FFI)
assess the improvement in ankle-foot functionality after treatment.
Time frame: 3 months
quality of life (SF12)
assess the improvement in the patient\'s quality of life after treatment.
Time frame: 3 months
Plan to share: No
Start is estimated for Oct 2024; primary completion for Feb 2025, 4 months later.
Of 104 non-industry interventional studies with no phase under Fasciitis, Plantar, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 21. This study's planned 4 months is below that.
Counting every sponsor, half of 109 studies reached it within 11 months; a quarter within 6 and three quarters within 22.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.